{{Rsnum
|rsid=1065776
|Gene=P2RY1
|Chromosome=3
|position=152835839
|Orientation=plus
|GMAF=0.08724
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=P2RY1
}}{{PharmGKB
|RSID=rs1065776
|Name_s=P2RY1:893C>T
|Gene_s=P2RY1
|Feature=
|Evidence=PubMed ID:19740098
|Annotation=Risk or phenotype-associated allele: C. Phenotype: An in vitro PFA-100 analysis was performed within 4 h of phlebotomy (blood drawn from healthy volunteers), using CADP and CEPI cartridges. P2RY1: 893C>T significantly effected platelet responses to collagen plus ADP (CADP). After accounting for multiple testing (Bonferroni adjustment), a statistically significant inverse correlation remained between CADP CT and P2RY1 893C (adjusted P = 0.032).
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165291885
}}

{{PharmGKB
|RSID=rs1065776
|Name_s=P2RY1:C893T
|Gene_s=P2RY1
|Feature=
|Evidence=PubMed ID:15757620; PubMed ID:17559347
|Annotation=Associations found with resistance to aspirin in terms of platelet aggregation.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161145102
}}

{{PharmGKB
|RSID=rs1065776
|Name_s=P2RY1:893C>T
|Gene_s=P2RY1
|Feature=
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/p2ry1/variant.jsp
|Annotation=Contrarily results regarding the association with aspirin resistance are published for this variant.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=In-Depth
|PharmGKB Accession ID=PA161845836
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1065776
|overall_frequency_n=911
|overall_frequency_d=10758
|overall_frequency=0.0846812
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=10
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}